0
0
Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA - StreetInsider.com
12/26/22 at 4:26pm
Organization
StreetInsider.com
51 words
0
Comments
Low-cost, over-the-counter naloxone nasal spray advances to FDA review. Approval would increase access to this lifesaving medicine for the emergency treatment of opioid overdose. PITTSBURGH,...
You are the first to view
https://www.streetinsider.com/PRNewswire/Harm+Reduction+Therapeutics+New+Drug+Application+for+RiVive%E2%84%A2+Over-the-Counter+Naloxone+Nasal+Spray+Accepted+and+Granted+Priority+Review+by+FDA/21005862.html
Create an account or login to join the discussion